TARRYTOWN, N.Y., Aug. 13, 2019 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the Chemistry, Manufacturing and Controls (CMC) Prior-Approval Supplement…Original Article
FDA Approves Eylea (aflibercept) Injection Prefilled Syringe
